Obesity and cervical ripening failure risk

Objective. To estimate the impact of obesity on cervical ripening with prostaglandin E2 (PGE2). Materials and method. A retrospective study compared the cervical ripening efficiency of PGE2 on patients with BMI above 30 kg/m2 and normal weight patients with BMI between 20 kg/m2 and 25 kg/m2. In case...

Full description

Saved in:
Bibliographic Details
Published in:The journal of maternal-fetal & neonatal medicine 2012-03, Vol.25 (3), p.304-307
Main Authors: Gauthier, Tristan, Mazeau, Sophie, Dalmay, François, Eyraud, Jean-Luc, Catalan, Cyril, Marin, Benoit, Aubard, Yves
Format: Article
Language:English
Subjects:
Adolescent
Adult
Body Mass Index
Cervical Ripening
Cervix Uteri
Cervix Uteri - drug effects
Cohort Studies
Dinoprostone
Dinoprostone - pharmacology
Dinoprostone - therapeutic use
E2 prostaglandin
failure
Female
Humans
Labor, Induced
Labor, Induced - methods
Life Sciences
Logistic Models
Obesity
Obesity - complications
Oxytocics
Oxytocics - pharmacology
Oxytocics - therapeutic use
Pregnancy
Pregnancy Complications
Retrospective Studies
Santé publique et épidémiologie
Treatment Failure
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective. To estimate the impact of obesity on cervical ripening with prostaglandin E2 (PGE2). Materials and method. A retrospective study compared the cervical ripening efficiency of PGE2 on patients with BMI above 30 kg/m2 and normal weight patients with BMI between 20 kg/m2 and 25 kg/m2. In case of a Bishop score (≤3), a dinoprostone tampon was used over 12 h. In case of a Bishop score (4;6), a dinoprostone gel was used over 6 h. Failure of first cervical ripening attempt was defined, as the persistence of a Bishop score
ISSN:1476-7058
1476-4954
DOI:10.3109/14767058.2011.575485